Cephalgia in ED responds to oxygen
– High-flow oxygen is commonly used for cluster headache. Might it work for all-comers with headache?
– This was a tiny randomized trial with three groups: 17 to high-flow oxygen for 15 minutes, 14 to high-flow air for 15 minutes, and 17 to nothing for 15 minutes prior to standard medical therapy. The oxygen group did far better with regard to time to relief, 40 vs. 110 or 120 minutes; length of stay was 57 vs. 210 or 180 minutes; CT was less; less pharmacotherapy was needed, 29% (oxygen group) vs. mid-80s% in the other groups; and headache intensity was much less using visual analog scale.
– Assuming no contraindications to high-flow oxygen, this small trial, if confirmed, could change the way we treat all headaches.
– Put high-flow oxygen on your next headache patient, and see if it works.
Veysman BD et al. Annals of Emergency Medicine, Volume 54, Issue 3, Pages S71-S71
Antimigraine efficacy has been well demonstrated in multiple high-quality clinical trials for chlorpromazine, metoclopramide, and prochlorperazine, and droperidol. In general, these medications are inexpensive, well tolerated, and at least as efficacious, if not more so, than any agent to which they have been compared. These medications should therefore be considered first-line therapy for acute migraine in the ED setting.
Of the four agents mentioned above, chlorpromazine has fallen out of favor because of profound orthostasis that may accompany administration of this medication. Of the remaining three agents, droperidol is probably the most effective, with 2-hour headache relief rates approaching 100%. The ideal dose, as determined by a high-quality dose-finding study, is 2.5 mg. This medication is commonly used and exceedingly safe, but a recent FDA warning about QT prolongation has caused some clinicians to perform an EKG before medication administration.
Prochlorperazine administered in doses of 10 mg is also highly effective, although not quite as effective as droperidol. Metoclopramide is typically administered as a 10-mg intravenous dose but has been well tolerated and efficacious when administered as repeated successive doses of 20 mg.
Metoclopramide, prochlorperazine, and droperidol can all be accompanied by extrapyramidal symptoms, particularly akathisia, which often goes unrecognized. Prophylactic administration of diphenhydramine is a reasonable course of action, as are slower intravenous drip rates.
Metoclopramide has a favorable pregnancy rating and a long history of use for treatment of hyperemesis gravidarum. It is the most appropriate parenteral agent for treatment of acute migraine in pregnancy.
Emergency Medicine Clinics of North America Volume 27, Issue 1, February 2009, Pages 71-87